Immediate Impact
31 standout
Citing Papers
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
2024 Standout
EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
2024 Standout
Works of Edip Erkuş being referenced
Is Neuregulin‐4 a predictive marker of microvascular complications in type 2 diabetes mellitus?
2020
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Edip Erkuş | 272 | 278 | 135 | 189 | 27 | 841 | |
| Özge Kurtkulağı | 185 | 287 | 238 | 180 | 31 | 857 | |
| Emin Murat Akbaş | 312 | 208 | 125 | 129 | 34 | 845 | |
| Levent Demirtaş | 270 | 185 | 96 | 113 | 30 | 728 | |
| Charles W. Sewell | 136 | 195 | 70 | 47 | 26 | 814 | |
| Anja Mühlfeld | 113 | 195 | 209 | 61 | 28 | 895 | |
| Charles F. Moore | 159 | 217 | 65 | 154 | 34 | 879 | |
| Aytekin Alçelik | 184 | 247 | 29 | 116 | 53 | 820 | |
| Ahmed A. Hasan | 94 | 73 | 188 | 208 | 39 | 741 | |
| U. Ott | 129 | 85 | 293 | 81 | 43 | 863 | |
| Akira Ohshima | 188 | 191 | 127 | 272 | 61 | 925 |
All Works
Login with ORCID to disown or claim papers
Loading papers...